Skip to Content Facebook Feature Image

China urges G7 to stop manipulating China-related issues: spokesman

China

China urges G7 to stop manipulating China-related issues: spokesman
China

China

China urges G7 to stop manipulating China-related issues: spokesman

2025-11-14 04:29 Last Updated At:05:17

China urged the G7 to abandon the Cold War mentality and ideological bias, stop manipulating issues related to China and contribute to solidarity and cooperation in the international community, Chinese Foreign Ministry spokesman Lin Jian said at a regular press briefing in Beijing on Thursday.

Lin was responding to a media query regarding a joint statement released at the G7 Foreign Ministers' Meeting.

"The joint statement of G7 Foreign Ministers' Meeting once again represents a mischaracterization of facts, a deliberate vilification of China, and a gross interference in China's internal affairs. China deplores and opposes that. The Taiwan question is purely China's internal affair. How to resolve the Taiwan question is a matter for the Chinese people, which tolerates no external interference. The situation in the East China Sea and the South China Sea is generally stable. The G7 should stop using maritime issues to stoke disputes, escalate tensions and undermine regional peace and stability. China has always been aboveboard on the Ukraine crisis. China has never provided lethal weapons to any party to the conflict and strictly controls the export of dual-use articles. We never accept the G7's blame-shifting or groundless accusation," Lin said.

"As regard to peace and security, China is the major country with the best track record. China is firmly committed to peaceful development and a national defense policy that is defensive in nature. China always keeps its nuclear strength at the minimum level required by national security. The G7 turns a blind eye to the U.S.' special and primary nuclear disarmament responsibility and the nuclear proliferation risks from AUKUS while directing the issue at China. This is a typical move of confusing right with wrong. China's measures to standardize and refine its export control system comply with international common practices and aim to better defend world peace and regional stability and to fulfill its international obligations. The so-called 'China's overcapacity' and 'non-market practices' have been proven false by facts and have no merits at all," he noted.

"The G7 should stop politicizing and weaponizing trade issues to refrain from disrupting international economic order and global industrial and supply chains. China once again urges the G7 to take a clear grasp of the global trend, abandon the Cold War mentality and ideological bias, stop manipulating issues related to China, stop interfering in China's internal affairs, and make more contributions to solidarity and cooperation in the international community," the spokesman continued.

China urges G7 to stop manipulating China-related issues: spokesman

China urges G7 to stop manipulating China-related issues: spokesman

China on Sunday unveiled an updated version of its national medical insurance drug list and the inaugural edition of the commercial insurance innovative drug list, according to the National Healthcare Security Administration.

The updated national medical insurance drug list has added 114 drugs, among which 50 are innovative pharmaceuticals. It has incorporated certain medications that fill the gaps in basic medical insurance coverage, such as drugs for major diseases, rare diseases, and chronic conditions.

The commercial insurance innovative drug list included 19 drugs for the treatment of tumors, rare diseases, and Alzheimer's, among others.

The country's medical insurance authority has adjusted the list for eight years in a row, increasing the total number of medications to 3,253 and significantly improving coverage in key areas such as oncology, chronic diseases, mental illnesses, rare diseases, and pediatric medications.

China updates national medical insurance catalog, adds 114 new drugs

China updates national medical insurance catalog, adds 114 new drugs

Recommended Articles